Automated site-directed drug design using molecular lattices.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Molecular Graphics

• Publication date

  1992-03-01

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1016/0263-7855(92)80038-FPMID 1637751
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular modeling software and methods for medicinal chemistry.

  1990cited by this paper
• Automated site-directed drug design: Approaches to the formation of 3D molecular graphs

  1990cited by this paper
• Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.

  1990cited by this paper
• SIRIUS. An automated method for the analysis of the preferred packing arrangements between protein groups.

  1990cited by this paper
• Automated site-directed drug design : the prediction and observation of ligand point positions at hydrogen-bonding regions on protein surfaces

  1989cited by this paper
• New hydrogen-bond potentials for use in determining energetically favorable binding sites on molecules of known structure.

  1989cited by this paper
• ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures

  1989cited by this paper
• Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution.

  1989cited by this paper
• Automated site-directed drug design: the concept of spacer skeletons for primary structure generation

  1989cited by this paper
• Automated site-directed drug design : the formation of molecular templates in primary structure generation

  1989cited by this paper
• Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure.

  1988cited by this paper
• A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.

  1985cited by this paper
• Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. I. General features and binding of methotrexate.

  1982cited by this paper
• A geometric approach to macromolecule-ligand interactions.

  1982cited by this paper
• Real-time color graphics in studies of molecular interactions.

  1981cited by this paper

• Subpocket Similarity-Based Hit Identification for Challenging Targets: Application to the WDR Domain of LRRK2

  2024cites this paper
• Structure-based drug design with geometric deep learning

  2022cites this paper
• A Guide to In Silico Drug Design

  2022cites this paper
• Modeling of Dopamine D2 Receptor - Overview of 35-Year Evolution.

  2015cites this paper
• Identification of HIV protease inhibitors by in silico screening

  2013cites this paper
• 1 De Novo Design : From Models to Molecules

  2013cites this paper
• The enumeration of chemical space

  2012cites this paper
• Development of methods for docking and designing small molecules within the Rosetta code framework

  2012cites this paper
• Enabling future drug discovery by de novo design

  2011cites this paper
• Site-directed fragment-based generation of virtual sialic acid databases against influenza A hemagglutinin

  2010cites this paper
• In Pursuit of Fully Flexible Protein‐Ligand Docking: Modeling the Bilateral Mechanism of Binding

  2010cites this paper
• The concept of template-based de novo design from drug-derived molecular fragments and its application to TAR RNA

  2008cites this paper
• A general method for exploiting QSAR models in lead optimization.

  2005cites this paper
• Comparison of automated docking programs as virtual screening tools.

  2005cites this paper
• Computer-based de novo design of drug-like molecules

  2005cites this paper
• Structure-based design of combinatorial libraries.

  2003cites this paper
• Principles of docking: An overview of search algorithms and a guide to scoring functions

  2002cites this paper
• A comparative docking study and the design of potentially selective MMP inhibitors

  2001cites this paper
• Accurate prediction of the bound conformation of galanthamine in the active site of Torpedo californica acetylcholinesterase using molecular docking.

  2001cites this paper
• Novel Cathepsin D Inhibitors Block the Formation of Hyperphosphorylated Tau Fragments in Hippocampus

  2000cites this paper
• Synergy between combinatorial chemistry and de novo design.

  2000cites this paper
• Characterizing Cavities in Model Inclusion Fullerenes: A Comparative Study

  2000cites this paper
• A Study on Binding Modes of Nonsteroidal Anti-inflammatory Drugs to COX1 and COX2 as Obtained by Dock4.0.

  1999cites this paper
• Prediction of binding constants of protein ligands: A fast method for the prioritization of hits obtained from de novo design or 3D database search programs

  1998cites this paper
• Flexible ligand docking using conformational ensembles

  1998cites this paper
• Characterization of receptors with a new negative image: Use in molecular docking and lead optimization

  1998cites this paper
• Characterizing cavities in model inclusion molecules: a comparative study.

  1998cites this paper
• A Monte Carlo method for finding important ligand fragments from receptor data

  1997cites this paper
• PRO_SELECT: Combining structure-based drug design and combinatorial chemistry for rapid lead discovery. 1. Technology

  1997cites this paper
• Molecular docking to ensembles of protein structures.

  1997cites this paper
• Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design

  1997cites this paper
• Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D.

  1997cites this paper
• Design of stapled DNA-minor-groove-binding molecules with a mutable atom simulated annealing method

  1997cites this paper
• The properties of known drugs. 1. Molecular frameworks.

  1996cites this paper
• Predicting the structure of protein complexes: a step in the right direction.

  1996cites this paper
• PRO_LIGAND: An approach to de novo molecular design. 4. Application to the design of peptides

  1995cites this paper
• PRO_LIGAND: An approach to de novo molecular design. 1. Application to the design of organic molecules

  1995cites this paper
• BUILDER v.2: Improving the chemistry of a de novo design strategy

  1995cites this paper
• PRO_LIGAND: An approach to de novo molecular design. 6. Flexible fitting in the design of peptides

  1995cites this paper
• PRO_LIGAND: An approach to de novo molecular design. 3. A genetic algorithm for structure refinement

  1995cites this paper
• Flexible ligand docking using a genetic algorithm

  1995cites this paper
• The atom assignment problem in automated de novo drug design. 1. Transferability of molecular fragment properties

  1995cites this paper
• Automated molecular design: A new fragment-joining algorithm

  1994cites this paper
• PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.

  1994cites this paper
• SPROUT: Recent developments in the de novo design of molecules

  1994cites this paper
• Advances in automated docking applied to human immunodeficiency virus type 1 protease.

  1994cites this paper
• An algorithm to find channels and cavities within protein crystals.

  1994cites this paper
• A shape- and chemistry-based docking method and its use in the design of HIV-1 protease inhibitors

  1994cites this paper
• Flexibases: A way to enhance the use of molecular docking methods

  1994cites this paper
• Current methods for site-directed structure generation

  1994cites this paper
• SPROUT: A program for structure generation

  1993cites this paper
• GenStar: A method for de novo drug design

  1993cites this paper
• FOUNDATION: A program to retrieve all possible structures containing a user-defined minimum number of matching query elements from three-dimensional databases

  1993cites this paper
• Chem-X and CAMBRIDGE. Comparison of computer generated chemical structures with x-ray crystallographic data

  1993cites this paper
• GroupBuild: a fragment-based method for de novo drug design.

  1993cites this paper
• Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation.

  1993cites this paper
• Structure-Based Strategies for Drug Design and Discovery

  1992cites this paper
• Computer-aided drug design: getting the best results.

  1992cites this paper
• Automated site-directed drug design: a method for the generation of general three-dimensional molecular graphs.

  1992cites this paper
• The MidasPlus molecular modeling system

  1992cites this paper